Aswin Krishnamurthy

Aswin Krishnamurthy

Auto-generated profile, based on publicly available information

Aswin Krishnamurthy

Department of Pharmacology Sri Ramachandra Faculty of Pharmacy Sri Ramachandra Institute of Higher Education and Research (DU) Chennai Tamil Nadu India

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2025 in Turkish Computational and Theoretical Chemistry
Verified
Journal Article
Open access
PDF file
AKAswin K
Aswin K
SMShabna Roupal Morais
Shabna Roupal Morais
Introduction: Glioblastoma multiforme (GBM) is a highly aggressive brain tumor that remains challenging to treat due to its resistance to conventional therapies. Despite advances in cancer research, GBM patients face low survival rates often surviving only a few months to a year after diagnosis. Nolatrexed shows notable pharmacological effects and promising therapeutic potential. We explore its interactions, pharmacokinetics and toxicity using computational tools Methods: In-silico investigations were conducted to analyse nolatrexed interactions with GBM targets using network pharmacology which identifies potential targets. The target nolatrexed was optimised and geometry was calculated for the Frontier molecular orbitals (FMO) and visualised using the 6-311(+)G(d)(p) basis set in Gauss View 16. Autodock tools 1.5.7 used for molecular docking, and the results were subsequently validated using Discovery Studio 4.5. ADMET analysed through ADMETlab 2.0, druglito and toxicity estimation software tool (T.E.S.T) . Result: In this study, FMO calculation was performed using Gaussian software were HOMO and LUMO ranges from 2.7059 to 7.9185 eV and shows higher energy gap signifies greater stability and lower reactivity The potential molecular targets of nolatrexed were first identifed using the Swiss Target Prediction platform and pathogenic targets of GBM were identifed using the Genecard, DisGeNET, and CTD database. Followed by compound and disease target overlapping, 69 targets were placed in that JUN, HSP90AA1, STAT3, MTOR, HSP90B1, IGF1R, GSK3B, JAK2, MAP2K1, and SIRT1 were the top-ranked target, which was estimated by CytoHubba plug-in. The molecular docking was performed for nolatrexed towards top 3 genes include mTORC1, mTORC2 and MAP2K1 from the PDB:7YRJ, 7TZO, 5HZE target. The binding score of nolatrexed were – 8.04 kcal/mol and – 7.2 kcal/ mol and -7.69 kcal/ mol respectively. Conclusion: Nolatrexed plays significant role in treatment of brain tumour, which helps to reduce GBM severity. Our findings suggest that nolatrexed hold promise as a potential therapy for GBM.

1 July 2026 in Current Pharmaceutical Analysis
Verified
Journal Article
Open access
KMKeren Celestina Mendonce
Keren Celestina Mendonce
NPNaveen Palani
Naveen Palani
AKAswin Krishnamurthy
Aswin Krishnamurthy
NSNandhini Sundaresan
Nandhini Sundaresan
SRSuriyaprakash Rajadesingu
Suriyaprakash Rajadesingu

31 July 2026 in Annals of Clinical Nutrition and Metabolism
Verified
Journal Article
Open access
AKAswin Krishnamurthy
Aswin Krishnamurthy
NSNandhini Sundaresan
Nandhini Sundaresan
VGVivekananthan Govindaraj
Vivekananthan Govindaraj
NSNANDHINI SUNDARESAN
NANDHINI SUNDARESAN
Purpose: Micronutrients play critical and multifaceted roles in the biological processes governing endodontic healing. This review aimed to evaluate the therapeutic roles of essential micronutrients, including vitamin D, vitamin C, calcium, zinc, magnesium, and selenium, in modulating immune responses, promoting tissue repair, and enhancing bone regeneration during endodontic healing.Current concept: The findings indicate that vitamin D supports odontoblast differentiation, immune regulation, and modulation of inflammatory pathways, whereas vitamin C enhances collagen synthesis, antioxidant protection, and pulp regeneration. Calcium and phosphorus are vital for hydroxyapatite formation and dentin mineralization, whereas zinc contributes to immune balance, enzymatic activation, and wound repair. Magnesium exhibits anti-inflammatory and bone-supportive properties, and selenium provides antioxidant and antimicrobial defense. Clinical studies have associated micronutrient deficiencies with delayed healing, increased infection risk, and reduced treatment success. Emerging innovations, such as bioactive sealants that release therapeutic minerals and diagnostic tools for nutrient profiling, highlight new directions in personalized endodontic care.Conclusion: Integrating micronutrient assessment and targeted supplementation strategies into clinical endodontic practice may optimize healing responses, minimize inflammation, and improve long-term treatment outcomes.

26 August 2026 in ChemistrySelect
Verified
Journal Article
Open access
PDF file
AKAswin Krishnamurthy
Aswin Krishnamurthy
Srikanth JeyabalanSrikanth Jeyabalan
Srikanth Jeyabalan
YAYukthasree Prasanth Athikari
Yukthasree Prasanth Athikari
NSNaveen Kumar Sukumar
Naveen Kumar Sukumar
NRNaveen Kumar Rajasekaran
Naveen Kumar Rajasekaran
TTTamilanban Thamaraikani
Tamilanban Thamaraikani
Alzheimer's disease (AD) lacks effective disease‐modifying therapies, highlighting the need for novel CNS‐targeted drug candidates. This study employs an integrated computational framework, combining a custom NeuroScore‐based CNS screening, network pharmacology, molecular docking, and molecular dynamics (MD) simulations, to identify 2,1,3‐benzothiadiazole derivatives as potential AD therapeutics. Screening 52,931 PubChem compounds yielded a top candidate (ID: 143693958; NeuroScore: 25.86; MW: 313.4 Da, LogP: 3.12, TPSA: 41.8 Å 2 ). Network pharmacology identified 87 AD‐overlapping targets, pinpointing serotonin transporter (SERT) as the key therapeutic target via serotonergic pathway enrichment. Molecular docking demonstrated strong SERT binding affinity (MolDock score: −132.72 kcal/mol), surpassing reference paroxetine (−130.51 kcal/mol). A 200 ns MD simulation confirmed structural stability (RMSD: 0.22 ± 0.03 nm; R g : 2.38 nm), and MM‐PBSA analysis revealed favorable binding free energy (−18.39 kJ/mol), driven predominantly by van der Waals interactions (−184.38 kJ/mol). ADMET profiling predicted excellent intestinal absorption (94.34%) with no AMES toxicity. This study presents a benzothiadiazole derivative as a promising SERT‐modulating lead for AD, establishing a robust computational foundation for experimental validation.